| Product Code: ETC11530660 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Romania Companion Diagnostic Market Overview |
3.1 Romania Country Macro Economic Indicators |
3.2 Romania Companion Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Romania Companion Diagnostic Market - Industry Life Cycle |
3.4 Romania Companion Diagnostic Market - Porter's Five Forces |
3.5 Romania Companion Diagnostic Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 Romania Companion Diagnostic Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Romania Companion Diagnostic Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.8 Romania Companion Diagnostic Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.9 Romania Companion Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Romania Companion Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of personalized medicine in Romania |
4.2.2 Growing prevalence of chronic diseases in the country |
4.2.3 Supportive government initiatives and funding for healthcare infrastructure development |
4.3 Market Restraints |
4.3.1 High cost associated with companion diagnostic tests |
4.3.2 Limited awareness and understanding of companion diagnostics among healthcare providers and patients |
4.3.3 Regulatory challenges and delays in approval processes |
5 Romania Companion Diagnostic Market Trends |
6 Romania Companion Diagnostic Market, By Types |
6.1 Romania Companion Diagnostic Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Romania Companion Diagnostic Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 Romania Companion Diagnostic Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.1.4 Romania Companion Diagnostic Market Revenues & Volume, By Immunohistochemistry, 2021 - 2031F |
6.1.5 Romania Companion Diagnostic Market Revenues & Volume, By Next-Gen Sequencing, 2021 - 2031F |
6.1.6 Romania Companion Diagnostic Market Revenues & Volume, By Mass Spectrometry, 2021 - 2031F |
6.2 Romania Companion Diagnostic Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Romania Companion Diagnostic Market Revenues & Volume, By Drug Response Testing, 2021 - 2031F |
6.2.3 Romania Companion Diagnostic Market Revenues & Volume, By Biomarker Testing, 2021 - 2031F |
6.2.4 Romania Companion Diagnostic Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.2.5 Romania Companion Diagnostic Market Revenues & Volume, By Disease Identification, 2021 - 2031F |
6.3 Romania Companion Diagnostic Market, By Disease Area |
6.3.1 Overview and Analysis |
6.3.2 Romania Companion Diagnostic Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.3 Romania Companion Diagnostic Market Revenues & Volume, By Cardiology, 2021 - 2031F |
6.3.4 Romania Companion Diagnostic Market Revenues & Volume, By Neurology, 2021 - 2031F |
6.3.5 Romania Companion Diagnostic Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.4 Romania Companion Diagnostic Market, By Sample Type |
6.4.1 Overview and Analysis |
6.4.2 Romania Companion Diagnostic Market Revenues & Volume, By Blood, 2021 - 2031F |
6.4.3 Romania Companion Diagnostic Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.4.4 Romania Companion Diagnostic Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.4.5 Romania Companion Diagnostic Market Revenues & Volume, By Urine, 2021 - 2031F |
6.5 Romania Companion Diagnostic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Romania Companion Diagnostic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 Romania Companion Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5.4 Romania Companion Diagnostic Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5.5 Romania Companion Diagnostic Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
7 Romania Companion Diagnostic Market Import-Export Trade Statistics |
7.1 Romania Companion Diagnostic Market Export to Major Countries |
7.2 Romania Companion Diagnostic Market Imports from Major Countries |
8 Romania Companion Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of personalized medicine in Romania |
8.2 Number of partnerships and collaborations between diagnostic companies and healthcare institutions |
8.3 Investments in research and development of new companion diagnostic technologies |
8.4 Rate of integration of companion diagnostics into clinical practice |
8.5 Number of clinical trials incorporating companion diagnostics as part of treatment protocols |
9 Romania Companion Diagnostic Market - Opportunity Assessment |
9.1 Romania Companion Diagnostic Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 Romania Companion Diagnostic Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Romania Companion Diagnostic Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
9.4 Romania Companion Diagnostic Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
9.5 Romania Companion Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Romania Companion Diagnostic Market - Competitive Landscape |
10.1 Romania Companion Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Romania Companion Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here